Sitemap
January 30, 2008 Articles
Filter by Available Specialty
- Allergan reports 32% increase in fourth-quarter sales; oral glaucoma drug fails second phase 3 trial
- Ankle fractures in the elderly associated with low complication rate, regardless of treatment type
- Lux Biosciences granted FDA fast track designation for corneal transplant rejection drug
- PEDF may regulate corneal vascularization, prevent retinal neovascularization, study suggests
- Timolol may reduce post-phaco IOP increases in patients with glaucoma, exfoliation syndrome